Study of some physiological and histological effects of gemfibrozil Drug in Pancreas Tissue of male Albino rats
Article Sidebar
-
Obesity, Pancreatic lipase, Gemfibrozil, Hyperlipidemia, Acini
Abstract
Gemfibrozil is the medication for long-term control of obesity that the FDA has approved by inhibiting Pancreatic lipase , it decreases the absorption of dietary fat. The purpose of the current study is to provide light on potential gemfibrozil in treatment of pancreatic disorder in induced hyperlipidemic rats which caused by high fat diet and how these changes may affect the physiology of the lipase enzyme. Used 40 male albino obese rats with mean 12 weeks .The animal divide to five Groups and all group include of these 8 animals . The first group is control , second group induced hyperlipidimic rats give high fat diet untreated group , third group induced hyperlipidimic rats then treated by gimfibrozil (600 mg/kg/day) , fourth group induced hyperlipidimic rats then treated by gimfibrozil (1200 mg/kg/day) and fifth group induced hyperlipidimic rats then treated by gimfibrozil (1500mg/kg/day). The results showed significant increased (P≤ 0.05) pancreatic lipase in group 2(high fat diet ) in compared to other group. Hyperlipidemia caused acute pancreatitis , Severe necrosis of beta and alpha cells of Langerhans islets led to form spaces in Langerhans islet, also these spaces filled with lymphocytes that occupied most of affected Langerhans islet area in second group ( high fat diet). Conclusion: Gemfibrozil is recommended in the treatment hyperlipidemia by reduces triglyceride levels that caused pancreatic tissue degeneration, dilation of pancreatic duct with retained secretion and congestion. inflammatory cell infiltration observed in pancreatic acini and vascular congestion with islets of Langerhans .
Full text article
References
Dominguez-Munoz, J.E., Malfertheiner, P., Ditschuneit, H.H., Blanco-Chavez, J., Uhl, W., Buchler, M., Ditschuneit, H., 1991. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Int. J. Pancreatol. 10, 261–267.
Toskes, P.P., 1990. Hyperlipidemic pancreatitis. Gastroenterol. Clin. North. Am. 19, 783–791.
Yadav, D., Pitchumoni, C.S., 2003. Issues in hyperlipidemic pancreatitis. J. Clin. Gastroenterol. 36, 54–62.
Zieve, L., 1968. Relationship between acute pancreatitis and hyperlipemia. Med. Clin. North Am. 52, 1493–1501.
Ferdinandy, P., Szilvássy, Z., Horváth, L.I., Csont, T., Csonka, C., Nagy, E., Szentgyörgyi, E., Nagy, I., Koltai, M., Dux, L., 1997. Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J. Mol. Cell Cardiol. 29, 3321–3333.
Deliconstantinos, G., Villiotou, V., Stavrides, J.C., 1995. Modulation of particulate nitric oxide synthase activity and peroxynitrite synthesis in cholesterol enriched endothelial cell membranes. Biochem. Pharmacol. 49, 1589–1600.
Standring, S. (2016). Lymphoid tissues. Gray's anatomy: the anatomical basis of clinical practice (41st ed.). Philadelphia, 73-4.
Yamada, T., Hasler, W. L., and Inadomi, J. M. (2005). “Structural anomalies and hereditary diseases of the pancreas,” in Gastroenter-ology, ed. Y. Yamada (Philadelphia, PA: Lippincott Williams & Wilkins), 80–90.
Gorelick, F. S., Pandol, S., & Jamieson, J. D. (2018). Structure-function relationships in the pancreatic acinar cell. In Physiology of the gastrointestinal tract (pp. 869-894). Academic Press.
Cook N et al (2021.) Essentials of Anatomy and Physiology for Nursing Practice. SAGE Publications.
Altunkaynak, Z. (2005). Effects of high fat diet induced obesity on female rat livers (a histochemical study). Eur J Gen Med 2005; 2(3):100-109
Earnest E., Ekene., Nwoke. and Ejaghaku L., (2014). Guidelines on dosage calculation and stock solution preparation in experimental animals’ studies. Journal of Natural Sciences Research.
Ewald N, Hardt PD, Kloer H. Severe hypertriglyceridemia and pancreatitis: presentation and management. Curr Opin Lipidol. 2009;20:497-504.
Searles GE, Ooi TC. Underrecognition of chylomicronemia as a cause of acute pancreatitis. CMAJ. 1992;147(12):1806-1808.
Jain D, Zimmerschied J. Heparin and insulin for hypertriglyceridemia-induced pancreatitis: case report. Sci World J. 2009;9:1230-1232.
Poonuru S, Pathak S, Vats H, Pathak R. Rapid reduction of severely elevated serum triglycerides with insulin infusion, gemfibrozil and niacin. Clin Med Res. 2011;9(1):38-41.
Stefanutti C, Labbadia G, Morozzi C. Severe hypertriglyceridemia-related acute pancreatitis. Ther Apher Dial. 2013;17(2):130-137. doi: 10.1111/1744-9987.12008.
Oh HC, Kwon CI, El Hajj II, Easler JJ, Watkins J, Fogel EL, McHenry L, Sherman S, Zimmerman MK, Lehman GA. Low Serum Pancreatic Amylase and Lipase Values Are Simple and Useful Predictors to Diagnose Chronic Pancreatitis. Gut Liver. 2017 Nov 15;11(6):878-883.
Inácio MD, Rafacho A, de Paula Camaforte NA, Teixeira P, Vareda PMP, Violato NM, Bosqueiro JR. Prevention of Elevation in Plasma Triacylglycerol with High-Dose Bezafibrate Treatment Abolishes Insulin Resistance and Attenuates Glucose Intolerance Induced by Short-Term Treatment with Dexamethasone in Rats. Int J Endocrinol. 2018;2018:3257812.
Spencer, C.M., Barradell, L.B. Gemfibrozil. Drugs 51, 982–1018 (1996).
Panek J. and Zasada J., (2007). The role of nitric oxide (NO) in acute pancreatitis. Przegl Lek. 495–497.
Keklikoglu N., (2008). Inducible nitric oxide synthase immunoreactivity in healthy rat pancreas. Folia Histochem Cytobiol. 46:213 -7.
Al-Janabi N , Jawad M, Sharhan A, Madani Z, Jawad M, Agresh M. CLINICAL AND EPIDEMIOLOGICAL FEATURES OF 210 COVID-19 PATIENTS IN BABYLON GOVERNORATE DURING 2020. World Bulletin of Public Health.2021; 5:86-92.
Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.